Orthofix Medical Inc. Payments for Restructuring
Orthofix Medical Inc. (OFIX) reported Payments for Restructuring of $4.40 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2021-02-26
- Orthofix Medical Inc. payments for restructuring for the quarter ending 2020-12-31 was $2.30M.
- Orthofix Medical Inc. payments for restructuring for the quarter ending 2020-09-30 was $1.10M.
- Orthofix Medical Inc. payments for restructuring for the quarter ending 2020-06-30 was $900.00K.
- Orthofix Medical Inc. payments for restructuring for the quarter ending 2020-03-31 was $100.00K.
- Orthofix Medical Inc. payments for restructuring for fiscal 2020 was $4.40M.
- Orthofix Medical Inc. payments for restructuring for fiscal 2016 was $100.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2020-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $3.40M derived: sum of 2 quarters · filed 2021-02-26 | $4.30M derived: sum of 3 quarters · filed 2021-02-26 | $4.40M 10-K · filed 2021-02-26 |
| 2020-09-30 | $1.10M 10-Q · filed 2020-11-05 | $2.00M derived: sum of 2 quarters · filed 2020-11-05 | $2.10M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $900.00K 10-Q · filed 2020-08-06 | $900.00K 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $100.00K derived: 10-K 12 month − 3 quarters · filed 2021-02-26 | |||
| 2017-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $600.00K 10-Q · filed 2017-08-07 | ||
| 2017-03-31 | $200.00K 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | $100.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |